United States · 
What does Kearny Venture Partners invest in?
Kearny Venture Partners invests most often at Series C and Series B (52% of the rounds on record), in sectors such as Connected-health, Healthier Living and E-health.
Kearny Venture Partners highlights
- 01
23 rounds on record
- 02
Mostly Series C and Series B: 52% of its rounds
- 03
2 exits from the portfolio
What they do
Kearny Venture Partners is a healthcare investment firm exclusively focused on emerging healthcare products.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Connected-healthHealthier LivingE-health
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first23 appearances
- 2015
1 round
- Jul
- 2014
1 round
- Apr
- 2013
6 rounds
- Dec
- Nov
- Nov
- Oct
- Jun
- May
- 2012
4 rounds
- Aug
- Jun
- Mar
- Jan
- 2011
3 rounds
- Sept
- Apr
- Jan
- 2010
3 rounds
- Aug
- Aug
- Jun
- 2009
1 round
- Nov
- 2008
3 rounds
- Sept
- Mar
- Jan
- 2007
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
AIAndrew Irving JensenChief Financial Officer/ Chief Compliance OfficeriForm ADV
CMCaley Mcneill CasteleinManaging Member of the General PartneriFiling they signed
JSJim ShapiroManaging Member of the General PartneriFiling they signed
RSRichard SpaldingManaging Member of the General PartneriFiling they signed
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$319Massets it manages, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Kearny Venture Associates III, LLC
- SEC number
- CRD 309872
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
BaxanoBought by TranS1UndisclosedMar 2013
NextWave PharmaceuticalsBought by PfizerUndisclosedOct 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.